![Selective serotonin reuptake inhibitors / Acetamides / Organofluorides / Treatment of bipolar disorder / Antidepressants / Agomelatine / Venlafaxine / Fluoxetine / Serotonin–norepinephrine reuptake inhibitor / Chemistry / Organic chemistry / Psychiatry Selective serotonin reuptake inhibitors / Acetamides / Organofluorides / Treatment of bipolar disorder / Antidepressants / Agomelatine / Venlafaxine / Fluoxetine / Serotonin–norepinephrine reuptake inhibitor / Chemistry / Organic chemistry / Psychiatry](https://www.pdfsearch.io/img/5eb06ed42b21fd339f5f83ddac512ba4.jpg) Date: 2015-03-06 00:23:40Selective serotonin reuptake inhibitors Acetamides Organofluorides Treatment of bipolar disorder Antidepressants Agomelatine Venlafaxine Fluoxetine Serotonin–norepinephrine reuptake inhibitor Chemistry Organic chemistry Psychiatry | | PUBLIC SUMMARY DOCUMENT Product: AGOMELATINE, tablet, 25mg, Valdoxan® Sponsor: Servier Laboratories (Australia) Pty Ltd Date of PBAC Consideration: March[removed]Purpose of ApplicationAdd to Reading ListSource URL: www.pbs.gov.auDownload Document from Source Website File Size: 383,86 KBShare Document on Facebook
|